Skip to main content
Lucio Nobile, MD, Oncology, Cutten, CA, Renown Regional Medical Center

LucioManlioNobileMD

Oncology Cutten, CA

Physician

Dr. Nobile is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Nobile's full profile

Already have an account?

Education & Training

  • Jacobi Medical Center/Albert Einstein College of Medicine
    Jacobi Medical Center/Albert Einstein College of MedicineFellowship, Hematology and Medical Oncology, 1994 - 1996
  • Sapienza University of Rome
    Sapienza University of RomeClass of 1982

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 2000 - Present
  • CA State Medical License
    CA State Medical License 2003 - 2026
  • NV State Medical License
    NV State Medical License 2020 - 2023
  • AL State Medical License
    AL State Medical License Active through 2007
  • WA State Medical License
    WA State Medical License 2001 - 2004
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • Analysis of Prognostic Factors Predictive of Event-Free Survival (EFS) Following Unrelated Donor (UD) Bone Marrow Transplantation (BMT) for Chronic Myeloid Leukemia (C...
    Nobile LM, Nevill TJ, Brockington DA, Nantel SH, Sutherlad HJ, Hogge DE, Toze CL, Conneally EA, Shepard JD, Barnett MJ, Leukemia/BMT Program of British Columbia, Division of Hematology, Vancouver General Hospital (VGH), British Columbia Cancer Agency and University of British Columbia, IBMTR/ABMTR Meeting, Vancouver, British Columbia, Canada, 3/1/2000
  • Donor Age Independently InfluencesEvent-Free Survival (EFS) Following Related Donor (RD) Stem Cell Transplantation (SCT) for Chronic Myeloid Leukemia (CML): Results of...
    L.M. Nobile, T.J. Nevill, D.A. Brockington, A.Lee, S.H. Nantel, H.J. Sutherland, D.E. Hogge, C.L.Toze, E.A. Coneally, J.D. Shepard and M. Barnett, Leukemia/BMT program ofBritish Columbia, Division ofHematology, Vancouver General Hospital (VGH), British Columbia Cancer Agency and the University of British Columbia; ASH, Vancouver, British Columbia, Canada, 1/1/1999
  • A unique Carboxy-Terminus Mutant of the Retinoic Acid Receptor Alpha Gene Associated with a Variant Marker Chromosome in a Retinoic Acid Resistant HL-60 Subline.
    C. Brigati, L.M. Nobile, Giusi Fugazza, Manahaz Zohouri, Robert Gallagher, Linda Canizzaro, Leukemia Research, 1/1/1999
  • Join now to see all

Hospital Affiliations